3 ms·
Exactly—please point to a pharma company that is doing original R&D and creating important products in a country where IP protections are weak.
by replicatorblog 11y ago
Exactly—please point to a pharma company that is doing original R&D and creating important products in a country where IP protections are weak.
- aravindet 11y agoThis is the correlation-causation confusion again. Some countries have big pharma companies, others don't. Big pharma companies can spend more on research as well as on lobbying to maintain over-the-top “IP” protections. The flaw in your reasoning is seeing the presence or absence of IP protection as an independent variable, and level of R&D as a function of that. I think both are dependent on the amount of cash pharma companies have to spend.